Dr. Bruno Silva-Santos
IMM - Instituto de Medicina Molecular
Bruno Silva-Santos is a Group Leader and Vice-Director of Instituto de Medicina Molecular, and Associate Professor of the Faculty of Medicine of the University of Lisbon. He did his PhD in Immunology at Cancer Research UK (The London Research Institute), and worked as a post-doctoral fellow at King’s College London. Since establishing his independent group at iMM in Lisbon, Bruno Silva-Santos has received Starting and Consolidator Grants from the European Research Council (ERC) and Installation and Young Investigator Grants from the European Molecular Biology Organization (EMBO). His research is dedicated to T cells, having dissected novel molecular mechanisms of T-cell differentiation and tumor cell recognition, published in journals such as Science or Nature Immunology, among a total of 75 papers. His translational work was recognized with various awards, including from University of Lisbon, Pfizer, Janssen and BIAL; and led to a start-up company focused on cancer immunotherapy, Lymphact, recently acquired by GammaDelta Therapeutics.